Navigation Links
The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation

BEVERLY HILLS, Calif., March 2, 2011 /PRNewswire/ -- The Center for Radiation Therapy of Beverly Hills, a state-of-the-art cancer treatment center serving cancer patients in the Los Angeles area, has been awarded a three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR) and The American Society for Radiation Oncology (ASTRO).

Radiation oncology (radiation therapy) is the careful use of high-energy radiation to treat cancer. A radiation oncologist may use radiation to cure cancer or to relieve a cancer patient's pain.

The ACR-ASTRO seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific practice guidelines and technical standards developed by ACR and ASTRO after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.

Patient care and treatment, patient safety, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are assessed in the review process. The findings are reported to the ACR-ASTRO Committee on Radiation Oncology Accreditation, which subsequently provides the practice with a comprehensive report it can use for continuous practice improvement.

The Center for Radiation Therapy of Beverly Hills, part of the Tower Hematology Oncology Medical Group, voluntarily underwent the rigorous review process to ensure the practice meets nationally accepted standards of care as determined by ACR. It is the first free-standing radiation center in California, and only the second radiation facility of any kind in the Los Angeles area, to earn the accreditation.

"We are honored to receive this prestigious accreditation, which acknowledges that the center's medical personnel are well qualified, through education and certification, to administer radiation therapy treatments," said Christopher M. Rose, M.D., Medical Director of The Center for Radiation Therapy of Beverly Hills and Chief Technology Officer of Valley Radiotherapy Associates. "We look forward to continuing to offer patients the most effective and up-to-date treatment options, and providing care that meets the highest quality standards."

Barry Rosenbloom, M.D., Managing Partner of the Tower Hematology Oncology Medical Group, said the accreditation reflects the entire group's commitment to safety and unsurpassed patient care.

"Earning the ACR-ASTRO accreditation ensures our patients that they will receive appropriate treatment from skilled medical professionals using superbly maintained equipment, in a facility that meets the most demanding professional benchmarks for safety and quality assurance," Dr. Rosenbloom asserted.

The ACR is a national professional organization serving more than 34,000 diagnostic and interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists, with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services. ASTRO is a professional organization serving more than 10,000 radiation oncologists, medical physicists, and other health care professionals involved in the treatment of cancer patients.

About The Center for Radiation Therapy of Beverly Hills

Established in 2006 by Tower Hematology Oncology Medical Group, The Center for Radiation Therapy of Beverly Hills (RTBH) is centrally located in the heart of Beverly Hills and adjacent to the cities of Santa Monica and Los Angeles. RTBH provides oncology patients with state-of-the-art radiation therapy care by a team of highly trained and experienced clinicians. Its above-ground design creates a highly accessible treatment environment. RTBH was the first treatment center in Southern California to implement RapidArc™ radiotherapy technology from Varian Medical Systems, a revolutionary breakthrough in cancer treatment that delivers powerful tumor-destroying radiation with unprecedented speed and remarkable precision. For more information, please visit

About Valley Radiotherapy Associates Medical Group, Inc.

Valley Radiotherapy Associates Medical Group, Inc. (VRA) was founded by Leslie E. Botnick, M.D. and Christopher M. Rose, M.D. in June 1983 to deliver quality radiation oncology services. Today, Manhattan Beach, Calif.-based VRA has 34 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California and Denver, Colorado. VRA has distinguished itself during the past 25 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit

SOURCE The Center for Radiation Therapy of Beverly Hills
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
7. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
8. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):